Severe pancreasitis is a very dangerous disease, and when it is co-infected, the situation becomes more complex and difficult, although, without fear, the following is a detailed account of what should be done in the case.
I. Timely diagnosis of infection
First, the doctor has to decide whether the infection was actually combined. Insulin patients themselves have abdominal pain, fever and vomiting symptoms, and when there is continued high fever, increased abdominal pain, rising white-cell count and low blood pressure, there is a high suspicion of co-infection. For example, Master Lee had severe pancreasitis in the hospital, which was stable at first, but after a few days he suddenly started a high fever, the temperature continued to fall, and the stomach ache, so the doctor quickly arranged for a further check to see if the infection was co-infection.
Identification of sources of infection and pathogens
Once the infection is suspected, the source of the infection should be identified as soon as possible, either as an infection in pancreas itself or as an infection in the surrounding tissues such as the peritoneal, larvae, etc. At the same time, culture is developed by extracting blood, abdominal water, fluids, etc., to determine which pathogen-induced infections are common, i.e. e. e., creber, intestinal fungi, etc. Like Mr. Li, he was given abdominal water test and found to be infected with pancreas.
III. Rational choice of antibacterial drugs
This is the key step. The choice of antibacterial drugs that can effectively fight pathogens and reach pancreas tissues through the blood pancreas barrier. In the case of carbon cyanide, for example, meropeacne, amphetamine, and so on, they have a wide spectrum of antibacterials, which are good for common pathogens and can better penetrate the haemorrhagic insulin barrier. And the third generation of gillin, like gills, is often chosen. In the case of Mr. Lee’s intestinal Eichil infection, the doctor gave him an appropriate dose of meropenan based on his sensitivity. In the case of anti-bacterial drugs, it is essential that they be taken on time and in accordance with medical instructions, and that they not be self-activated or replaced, since the unstandardized use of drugs can easily lead to resistance, which makes treatment more difficult.
IV. Strengthening support for treatment
Patients suffering from a combination of severe pancreas disease are weak and need adequate nutritional support. Sufficient nutrients, such as proteins, carbohydrates, fats, vitamins, etc., can be ensured to the patient, for example, by nasal feed or intravenous infusion. Master Li was unable to eat because of stomach pains, and the doctor put a nose feed on him and regularly injected nutrient-rich food into it. At the same time, care should be taken to maintain the hydrolytic balance of the patient, to monitor closely the vital signs of blood pressure, heart rate, urine, etc. of the patient, and to detect and address possible complications in a timely manner.
V. Surgery intervention if necessary
If the infection results in an abscess and the mere use of antibacterial drugs and support for treatment is not effective, it may require surgical treatment. The operation can draw out the abscess, remove the dead tissue, etc. For example, after a period of treatment, the infection around the pancreas formed a larger abscess, which was assessed by the doctor, which led to the discharge of the sepsis and the clean-up of some of the dead tissues, after which his condition slowly improved.
In short, co-infection with severe pancreas is a complex situation that requires the concerted efforts of doctors, nurses, patients and their families. Patients need to cooperate actively in treatment, family care and support, and doctors need to use their expertise to develop the most appropriate treatment programmes, in order to improve the patient ‘ s health rate and early recovery.
